not tagged
not tagged
['follicular', 'lymphoma', 'dlbcl']
the majority of the prospective landmark #clinicaltrials in follicular #lymphoma excludes #patients with (high-grade) fl3a and fl3b. most of the available #evidence is retrospective, causing a big gap in knowledge. should we shift any to #dlbcl? #eha2022 
Lymphoma Coalition | Head of Membership & Alliiances. 
Patient Advocate interested in R&D, Capacity Building, Patient's rights, Policy. Cooperation is my motto.